[HTML][HTML] Toll-like receptor signaling and its role in cell-mediated immunity

T Duan, Y Du, C Xing, HY Wang, RF Wang - Frontiers in Immunology, 2022 - frontiersin.org
Innate immunity is the first defense system against invading pathogens. Toll-like receptors
(TLRs) are well-defined pattern recognition receptors responsible for pathogen recognition …

[HTML][HTML] Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses

C Yujuan, LIN Junhong, Z Yao… - Journal of Zhejiang …, 2021 - ncbi.nlm.nih.gov
Abstract Toll-like receptor 3 (TLR3) is a member of the TLR family, mediating the
transcriptional induction of type I interferons (IFNs), proinflammatory cytokines, and …

[HTML][HTML] The use of toll-like receptor agonists in HIV-1 cure strategies

JT Martinsen, JD Gunst, JF Højen, M Tolstrup… - Frontiers in …, 2020 - frontiersin.org
Toll-like receptors (TLRs) are a family of pattern recognition receptors and part of the first
line of defense against invading microbes. In humans, we know of 10 different TLRs, which …

[HTML][HTML] Immunological approaches to HIV cure

AR Ward, TM Mota, RB Jones - Seminars in immunology, 2021 - Elsevier
Combination antiretroviral therapy (ART) to treat human immunodeficiency virus (HIV)
infection has proven remarkably successful–for those who can access and afford it–yet HIV …

[HTML][HTML] Application of built-in adjuvants for epitope-based vaccines

Y Lei, F Zhao, J Shao, Y Li, S Li, H Chang, Y Zhang - PeerJ, 2019 - peerj.com
Several studies have shown that epitope vaccines exhibit substantial advantages over
conventional vaccines. However, epitope vaccines are associated with limited immunity …

[HTML][HTML] Targeting cellular and tissue HIV reservoirs with toll-like receptor agonists

AB Macedo, CL Novis, A Bosque - Frontiers in immunology, 2019 - frontiersin.org
The elimination of both cellular and tissue latent reservoirs is a challenge toward a
successful HIV cure.“Shock and Kill” are among the therapeutic strategies that have been …

[HTML][HTML] Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T …

M Calvet-Mirabent, I Sánchez-Cerrillo… - …, 2022 - thelancet.com
Summary Background Dysfunction of CD8+ T cells in people living with HIV-1 (PLWH)
receiving anti-retroviral therapy (ART) has restricted the efficacy of dendritic cell (DC)-based …

[HTML][HTML] Role of TLRs in HIV-1 infection and potential of TLR agonists in HIV-1 vaccine development and treatment strategies

M Rozman, S Zidovec-Lepej, K Jambrosic, M Babić… - Pathogens, 2023 - mdpi.com
Toll-like receptors (TLRs), as a family of pattern recognition receptors, play an important role
in the recognition of HIV-1 molecular structures by various cells of the innate immune …

[HTML][HTML] HIV latency in myeloid cells: challenges for a cure

A Chitrakar, M Sanz, SB Maggirwar, N Soriano-Sarabia - Pathogens, 2022 - mdpi.com
The use of antiretroviral therapy (ART) for Human Immunodeficiency Virus (HIV) treatment
has been highly successful in controlling plasma viremia to undetectable levels. However, a …

A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection

FJ Barrat, L Su - Journal of Experimental Medicine, 2019 - rupress.org
Following the discovery of plasmacytoid dendritic cells (pDCs) and of their extraordinary
ability to produce type I IFNs (IFN-I) in response to TLR7 and TLR9 stimulation, it is assumed …